NCT05874141Completed
Comorbidities in Type 2 Diabetes Mellitus
Comorbidities in Type 2 Diabetes Mellitus: An Observational Study in Kharga City, New Valley Governate, Egypt
Source: ClinicalTrials.gov · Last updated 26 May 2026
Brief summary (registry, in English)
Type 2 diabetes mellitus (DM) has adopted a top priority as it is a disease with an increasing prevalence. The number of people living with DM has increased more than fourfold over the past 40 years to more than 460 million people today
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 295 (actual)
- First submitted
- 30 Mar 2023
- Start date
- 15 Nov 2023
- Primary completion date
- 30 Dec 2025
- Lead sponsor
- New Valley University
- Diseases
- Type 2 diabetes
- NCT number
- NCT05874141
What you commit to
- Study type: Interventional
- Participants enrolled: 295
- From 15 Nov 2023 to the primary completion date, 30 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with type 1 diabetes.
- Patients with secondary diabetes.
Who the study is looking for
- Patients with type 2 diabetes.
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| New Valley University Coordinator of this site? Confirm its status | Al Khārjah | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.